Startups
2021
VITALA TECHNOLOGIES SLA groundbreaking technology to gain unparalleled insights into metabolic kinetics
CERCA ownership
Barcelona, Spain
2005
Institut de Bioenginyeria de Catalunya (IBEC)
CERCA Center Contact
ES
Eduardo SalasHead. Technology Transfer and Business Development Office
Institut de Bioenginyeria de Catalunya (IBEC)Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Application Areas
Pharma industry - We can help you reduce the costs, increase the success rate and reduce animal tests. Our technology can be applied during the preclinical phase of drug development
Cosmetics industry - We can help you validate the toxicity and effectiveness of your skin care products by eliminating the need for animal testsChemical industryWe can help you validate the effectiveness of fertilisers in boosting the productivity of a crop or that of a pesticide in delivering required levels of toxicity
Pharma industry - We can help you reduce the costs, increase the success rate and reduce animal tests. Our technology can be applied during the preclinical phase of drug development
Cosmetics industry - We can help you validate the toxicity and effectiveness of your skin care products by eliminating the need for animal testsChemical industryWe can help you validate the effectiveness of fertilisers in boosting the productivity of a crop or that of a pesticide in delivering required levels of toxicity
Product description
Vitala brings together recognized technologies and multiple new patented technologies to develop an efficient and ethical treatment analysis that will revolutionize drug discovery as well as personalized medicine.
Through a series of technologies - Organ-on-Chip (OoC) and advanced magnetic resonance tools, Vitala delivers deep insights into metabolic kinetics at the cellular level.
This will save the pharmaceutical industry billions of dollars in drug testing and will allow clinics and hospitals to target treatments to specific patients, improving the quality of life and eliminating erroneous, or even hazardous, treatments.
Through a series of technologies - Organ-on-Chip (OoC) and advanced magnetic resonance tools, Vitala delivers deep insights into metabolic kinetics at the cellular level.
This will save the pharmaceutical industry billions of dollars in drug testing and will allow clinics and hospitals to target treatments to specific patients, improving the quality of life and eliminating erroneous, or even hazardous, treatments.